[1]李 喆,朱淑华,陈 晨,等.1例狼疮性肠炎病人的营养支持治疗案例分析[J].肠外与肠内营养杂志,2025,(01):60-64.[doi:10.16151/j.1007-810x.2025.01.010]
点击复制

1例狼疮性肠炎病人的营养支持治疗案例分析()
分享到:

《肠外与肠内营养》杂志[ISSN:1007-810X/CN:32-1477/R]

卷:
期数:
2025年01期
页码:
60-64
栏目:
病例报告
出版日期:
2025-04-02

文章信息/Info

作者:
李 喆 1朱淑华 1陈 晨 2高学金 3
1.东部战区总医院国家肾脏疾病临床医学研究中心,江苏南京 210016;2.南京鼓楼医院临床营养科,江苏南京 210008;3.东部战区总医院普通外科,江苏南京 210016
关键词:
狼疮性肠炎 假性肠梗阻 免疫抑制 营养支持治疗
分类号:
R459.3
DOI:
10.16151/j.1007-810x.2025.01.010
文献标志码:
B

参考文献/References:


[1] Correa-Rodríguez M, Pocovi-Gerardino G, Callejas-Rubio JL, et al. The prognostic nutritional index and nutritional risk index are associated with disease activity in patients with systemic lupus erythematosus[J]. Nutrients, 2019, 11(3): 638.
[2] 中国营养学会医用食品与营养支持分会, 中华医学会肠外肠内营养学分会, 上海市医学会肠外肠内营养学专科分会, 等. 成人肠外营养维生素应用专家共识[J]. 肠外与肠内营养, 2024, 31(4): 193-210.
[3] 亚洲急危重症协会中国腹腔重症协作组. 重症病人胃肠功能障碍肠内营养专家共识(2021 版)[J]. 中华消化外科杂志, 2021,20(11): 1123-1136.
[4] 吴晨敏, 高 飞, 魏骐骄, 等. GLIM营养不良诊断标准在系统性红斑狼疮病人中的应用[J]. 肠外与肠内营养, 2022, 29(5): 268-273.
[5] Ahn SS, Jung SM, Song JJ, et al. Prognostic nutritional index is correlated with disease activity in patients with systemic lupuserythematosus[J]. Lupus, 2018, 27(10): 1697-1705.
[6] 苗译亓, 李 喆, 许书添, 等. 重症监护病房收治重症活动性狼疮性肾炎患者的临床特征及转归[J]. 肾脏病与透析肾移植杂志, 2021, 30(4): 321-326.
[7] 李 喆, 许书添, 胡伟新, 等. 系统性红斑狼疮合并持续炎症-免疫抑制-分解代谢综合征[J]. 肾脏病与透析肾移植杂志, 2020,29(2): 101-107.
[8] Islam MA, Khandker SS, Kotyla PJ, et al. Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus(SLE): a systematic review[J]. Front Immunol, 2020, 11: 1477.
[9] 谢敏珠, 陈 欣, 刘正钊, 等. 狼疮性肾炎合并狼疮性肠炎患者的临床特征及远期疗效分析[J]. 肾脏病与透析肾移植杂志, 2021, 30(1): 19-24.
[10] Chng HH, Tan BE, Teh CL, et al. Major gastrointestinal manifestations in lupus patients in Asia: lupus enteritis, intestinalpseudo-obstruction, and protein-losing gastroenteropathy[J]. Lupus, 2010, 19(12): 1404-1413.
[11] Yuan SW, Ye YJ, Chen DY, et al. Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence andprognosis of disease[J]. Semin Arthritis Rheum, 2014, 43(6):759-766.
[12] Zizic TM, Classen JN, Stevens MB. Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa[J]. Am J Med, 1982, 73(4): 525-531.
[13] Chowichian M, Aanpreung P, Pongpaibul A, et al. Lupus enteritis as the sole presenting feature of systemic lupus erythematosus: case report and review of the literature[J]. Paediatr Int Child Health, 2019, 39(4): 294-298.
[14] Janssens P, Arnaud L, Galicier L, et al. Lupus enteritis: from clinical findings to therapeutic management[J]. Orphanet J RareDis, 2013, 8: 67.
[15] Yoshida Y, Omoto T, Kohno H, et al. Lower CH50 as a predictor for intractable or recurrent lupus enteritis: a retrospectiveobservational study[J]. Mod Rheumatol, 2021, 31(3): 643-648.
[16] Yang YF, Bartsch AM, Fryer E, et al. Lupus causing small bowel obstruction[J]. BMJ Case Rep, 2018, 2018: bcr2018225886.
[17] Shin JI, Li H, Park S, et al. Induction and maintenance treatment of lupus nephritis: a comprehensive review of meta-analyses[J]. J Clin Med, 2022, 11(2): 343.
[18] 张靖垚, 杨斯宁, 加 佳, 等. 重症病人肠内营养实施新思考及实践[J]. 中华消化外科杂志, 2021, 20(11): 1162-1166.
[19] Koo BS, Hong S, Kim YJ, et al. Lupus enteritis: clinical characteristics and predictive factors for recurrence[J]. Lupus, 2015, 24(6): 628-632.

备注/Memo

备注/Memo:
基金项目 :东部战区总医院院内课题(22JCYYYB8、2023JCYJYB126)通讯作者 :高学金,E-mail: 547625433@qq.com共同通讯作者 :陈 晨,E-mail: chenchen055@163.com
更新日期/Last Update: 1900-01-01